Article Information
History
- August 7, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Katharine H.D. Crawford1,2,3,
- Adam S. Dingens1,
- Rachel Eguia1,
- Caitlin R. Wolf4,
- Naomi Wilcox4,
- Jennifer K. Logue4,
- Kiel Shuey4,
- Amanda M. Casto4,
- Brooke Fiala5,6,
- Samuel Wrenn5,6,
- Deleah Pettie5,6,
- Neil P. King5,6,
- Helen Y. Chu4,* and
- Jesse D. Bloom1,2,7,*
- 1Division of Basic Sciences and Computational Biology Program, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
- 2Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA
- 3Medical Scientist Training Program, University of Washington, Seattle, WA 98195, USA
- 4Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA 98195, USA
- 5Department of Biochemistry, University of Washington, Seattle, WA 98109, USA
- 6Institute for Protein Design, University of Washington, Seattle, WA 98195, USA
- 7Howard Hughes Medical Institute, Seattle, WA 98103, USA
- ↵*Correspondence:
Helen Y. Chu, 750 Republican St. Seattle, WA 98109, (206) 897-6650, helenchu{at}uw.edu, Jesse D. Bloom, 1100 Fairview Ave. N Seattle, WA 98109, (206) 667-3603, jbloom{at}fredhutch.org
Posted August 07, 2020.
Dynamics of neutralizing antibody titers in the months after SARS-CoV-2 infection
